SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-104334
Filing Date
2022-04-13
Accepted
2022-04-13 16:26:35
Documents
18
Period of Report
2022-04-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d334311d8k.htm   iXBRL 8-K 30555
2 EX-1.1 d334311dex11.htm EX-1.1 199010
3 EX-5.1 d334311dex51.htm EX-5.1 13177
4 EX-99.1 d334311dex991.htm EX-99.1 10538
8 GRAPHIC g334311dsp_44.jpg GRAPHIC 4171
9 GRAPHIC g334311g0412135928676.jpg GRAPHIC 2682
10 GRAPHIC g334311g0412135929238.jpg GRAPHIC 1704
  Complete submission text file 0001193125-22-104334.txt   456758

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crnx-20220412.xsd EX-101.SCH 2864
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20220412_lab.xml EX-101.LAB 18739
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20220412_pre.xml EX-101.PRE 11713
12 EXTRACTED XBRL INSTANCE DOCUMENT d334311d8k_htm.xml XML 3481
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 22824962
SIC: 2834 Pharmaceutical Preparations